​Alexion cuts ties with two Cambridge biotechs in reorganization

The Connecticut-based drugmaker said it was terminating partnership agreements with Moderna Therapeutics and Blueprint Medicines as part of an effort to trim down its pipeline.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.